BVN vs EMN

BVN exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating solid operational and financial performance. Despite this, the stock trades at a significant premium to both the Graham Number ($24.27) and intrinsic value estimate ($12.53), raising valuation concerns. While profitability metrics are robust—evidenced by a 30.70% profit margin and 35.35% operating margin—earnings growth is negative year-over-year (-29.50%), creating a divergence between quality and momentum. Analysts concur with a 'hold' recommendation, aligning with the mixed signals between strong fundamentals and stretched valuation.

Eastman Chemical Company exhibits significant fundamental deterioration, highlighted by a Piotroski F-Score of 4/9 (Stable but weak) and a severe earnings collapse of -67.5% YoY. While the current price of $72.00 sits near the Graham Number ($69.44), it trades at a massive premium to its growth-based intrinsic value of $28.70. The combination of negative revenue growth, a high dividend payout ratio (81.22%), and a bearish technical trend (0/100) suggests the stock is overvalued relative to its current trajectory.